Evaheart, Inc.

Evaheart, Inc.

生物技术

Bellaire,Texas 2,017 位关注者

Our Mission: To return severe heart failure patients to their home with high quality of life.

关于我们

LEADING LVAD COMPANY IN THE STATE OF TEXAS Evaheart, Inc. ("EVI") is a medical device company based in the Texas Medical Center of Houston. EVI was established to gain regulatory approval and commercialize the EVAHEART?2 Left Ventricular Assist System in the North American market and start distribution in Europe. Under an FDA-approved IDE, a Multi-Center Prospective Randomized Clinical Trial (COMPETENCE TRIAL) of the EVAHEART?2 LVAS is currently ongoing in US. OUR MISSION To return severe heart failure patients to their home with high quality of life. WHAT WE'VE ACHIEVED - Over 9-year durability testing with no mechanical failure. - Regulatory clearance granted (by PMDA) and now clinically used in Japan - Total 183 EVAHEART? LVAS have been implanted to-date (July-2018). - IDE (Investigational Device Exemption) approved by the FDA. - IDE clinical trial (BTT trial) in North America is underway. - New miniaturized pump and inflow cannula are implemented. "RESPECT PULSATILITY"

网站
https://www.evaheart-usa.com
所属行业
生物技术
规模
11-50 人
总部
Bellaire,Texas
类型
合营企业
创立
2014
领域
Left Ventricular Assist Devices & Systems (LVAS)

产品

地点

  • 主要

    4900 Fournace Pl

    Suite 222

    US,Texas,Bellaire,77401

    获取路线

Evaheart, Inc.员工

动态

相似主页

查看职位

融资

Evaheart, Inc. 共 1 轮

上一轮

保密

US$100,000,000.00

Crunchbase 上查看更多信息